IBS Treatment Market Report

Global IBS Treatment Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Apr 02, 2021
  • PAGES：137
  • REPORT CODE：GMM641677
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Irritable bowel syndrome (IBS) is a common disorder that affects the digestive system. IBS is characterized by symptoms such as stomach cramps, bloating, diarrhea, and constipation, which impacts one’s everyday life. Although the cause of IBS is unknown, but few factors that cause IBS are severe infection, inflammation in the intestines, muscle contractions in the intestine, changes in bacteria in the gut, and abnormalities in the nerves.

    Rising prevalence of gastrointestinal diseases and disorder, geriatric population, unhealthy diet, anxiety, depression, and changing lifestyle in Americas are the key drivers of the Americas IBS market.

    The IBS Treatment is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global IBS Treatment market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the IBS Treatment industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global IBS Treatment Market Segmentations:

    By Players:

    • Ironwood Pharmaceuticals, Inc (US)

    • Probi (Sweden)

    • Innovate Biopharmaceuticals (US)

    • Alfasigma USA, Inc (Italy)

    • Pfizer Inc (US)

    • Valeant Pharmaceuticals (Canada)

    • Synthetic Biologics, Inc (US)

    • RedHill Biopharma Ltd (Israel)

    • Nestle (Switzerland)

    • Sebela Pharmaceuticals (Ireland)

    • Novartis AG (Switzerland)

    • Ardelyx, Inc (US)

    • AstraZeneca (UK)

    • Protagonist Therapeutics Inc (US)

    • Takeda Pharmaceutical Company Ltd (Japan)

    • Allergan Plc (Ireland)

    • Lexicon Pharmaceuticals, Inc (US)

    • Synergy Pharmaceuticals, Inc (US)

    • Astellas Pharma Inc (Japan)

    • Abbott Laboratories (US)

    • Sucampo Pharmaceuticals (US)

    • Ipsen (France)

    By Types:

    • IBS-D

    • IBS-C

    • IBS-M

    By End-User:

    • Hospitals

    • Clinics

    • Research Laboratories

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of IBS Treatment Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global IBS Treatment Market Size and Growth Rate of IBS-D from 2014 to 2026

      • 1.3.2 Global IBS Treatment Market Size and Growth Rate of IBS-C from 2014 to 2026

      • 1.3.3 Global IBS Treatment Market Size and Growth Rate of IBS-M from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global IBS Treatment Market Size and Growth Rate of Hospitals from 2014 to 2026

      • 1.4.2 Global IBS Treatment Market Size and Growth Rate of Clinics from 2014 to 2026

      • 1.4.3 Global IBS Treatment Market Size and Growth Rate of Research Laboratories from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico IBS Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey IBS Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea IBS Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa IBS Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina IBS Treatment Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of IBS Treatment Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of IBS Treatment by Major Types

      • 3.4.1 IBS Treatment Market Size and Growth Rate of IBS-D

      • 3.4.2 IBS Treatment Market Size and Growth Rate of IBS-C

      • 3.4.3 IBS Treatment Market Size and Growth Rate of IBS-M

    4 Segmentation of IBS Treatment Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of IBS Treatment by Major End-Users

      • 4.4.1 Market Size and Growth Rate of IBS Treatment in Hospitals

      • 4.4.2 Market Size and Growth Rate of IBS Treatment in Clinics

      • 4.4.3 Market Size and Growth Rate of IBS Treatment in Research Laboratories

    5 Market Analysis by Major Regions

    • 5.1 Global IBS Treatment Production Analysis by Major Regions

    • 5.2 Global IBS Treatment Consumption Analysis by Major Regions

    • 5.3 Global IBS Treatment Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America IBS Treatment Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe IBS Treatment Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific IBS Treatment Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa IBS Treatment Production, Import, Consumption and Export Analysis

    6 Product Commodity of IBS Treatment Market in Major Countries

    • 6.1 Top 5 Export Countries in IBS Treatment market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in IBS Treatment market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in IBS Treatment market from 2014 to 2019

    • 6.2 Top 5 Import Countries in IBS Treatment market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in IBS Treatment market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in IBS Treatment market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America IBS Treatment Landscape Analysis

    • 7.1 North America IBS Treatment Landscape Analysis by Major Types

    • 7.2 North America IBS Treatment Landscape Analysis by Major End-Users

    • 7.3 North America IBS Treatment Landscape Analysis by Major Countries

      • 7.3.1 United States IBS Treatment Market Volume and Growth Rate

      • 7.3.2 Canada IBS Treatment Market Volume and Growth Rate

      • 7.3.3 Mexico IBS Treatment Market Volume and Growth Rate

    8 Europe IBS Treatment Landscape Analysis

    • 8.1 Europe IBS Treatment Landscape Analysis by Major Types

    • 8.2 Europe IBS Treatment Landscape Analysis by Major End-Users

    • 8.3 Europe IBS Treatment Landscape Analysis by Major Countries

      • 8.3.1 Germany IBS Treatment Market Volume and Growth Rate

      • 8.3.2 UK IBS Treatment Market Volume and Growth Rate

      • 8.3.3 France IBS Treatment Market Volume and Growth Rate

      • 8.3.4 Italy IBS Treatment Market Volume and Growth Rate

      • 8.3.5 Nordic Countries IBS Treatment Market Volume and Growth Rate

      • 8.3.6 Spain IBS Treatment Market Volume and Growth Rate

      • 8.3.7 Belgium IBS Treatment Market Volume and Growth Rate

      • 8.3.8 Poland IBS Treatment Market Volume and Growth Rate

      • 8.3.9 Russia IBS Treatment Market Volume and Growth Rate

      • 8.3.10 Turkey IBS Treatment Market Volume and Growth Rate

    9 Asia Pacific IBS Treatment Landscape Analysis

    • 9.1 Asia Pacific IBS Treatment Landscape Analysis by Major Types

    • 9.2 Asia Pacific IBS Treatment Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific IBS Treatment Landscape Analysis by Major Countries

      • 9.3.1 China IBS Treatment Market Volume and Growth Rate

      • 9.3.2 Japan IBS Treatment Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand IBS Treatment Market Volume and Growth Rate

      • 9.3.4 India IBS Treatment Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries IBS Treatment Market Volume and Growth Rate

      • 9.3.6 South Korea IBS Treatment Market Volume and Growth Rate

    10 Latin America, Middle East & Africa IBS Treatment Landscape Analysis

    • 10.1 Latin America, Middle East & Africa IBS Treatment Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa IBS Treatment Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa IBS Treatment Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries IBS Treatment Market Volume and Growth Rate

      • 10.3.2 Brazil IBS Treatment Market Volume and Growth Rate

      • 10.3.3 Nigeria IBS Treatment Market Volume and Growth Rate

      • 10.3.4 South Africa IBS Treatment Market Volume and Growth Rate 

      • 10.3.5 Argentina IBS Treatment Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Ironwood Pharmaceuticals, Inc (US)

      • 11.1.1 Ironwood Pharmaceuticals, Inc (US) Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Probi (Sweden)

      • 11.2.1 Probi (Sweden) Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Innovate Biopharmaceuticals (US)

      • 11.3.1 Innovate Biopharmaceuticals (US) Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Alfasigma USA, Inc (Italy)

      • 11.4.1 Alfasigma USA, Inc (Italy) Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Pfizer Inc (US)

      • 11.5.1 Pfizer Inc (US) Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Valeant Pharmaceuticals (Canada)

      • 11.6.1 Valeant Pharmaceuticals (Canada) Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Synthetic Biologics, Inc (US)

      • 11.7.1 Synthetic Biologics, Inc (US) Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 RedHill Biopharma Ltd (Israel)

      • 11.8.1 RedHill Biopharma Ltd (Israel) Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Nestle (Switzerland)

      • 11.9.1 Nestle (Switzerland) Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Sebela Pharmaceuticals (Ireland)

      • 11.10.1 Sebela Pharmaceuticals (Ireland) Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Novartis AG (Switzerland)

      • 11.11.1 Novartis AG (Switzerland) Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Ardelyx, Inc (US)

      • 11.12.1 Ardelyx, Inc (US) Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 AstraZeneca (UK)

      • 11.13.1 AstraZeneca (UK) Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 Protagonist Therapeutics Inc (US)

      • 11.14.1 Protagonist Therapeutics Inc (US) Company Profile and Recent Development

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Takeda Pharmaceutical Company Ltd (Japan)

      • 11.15.1 Takeda Pharmaceutical Company Ltd (Japan) Company Profile and Recent Development

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Allergan Plc (Ireland)

      • 11.16.1 Allergan Plc (Ireland) Company Profile and Recent Development

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 Lexicon Pharmaceuticals, Inc (US)

      • 11.17.1 Lexicon Pharmaceuticals, Inc (US) Company Profile and Recent Development

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 Synergy Pharmaceuticals, Inc (US)

      • 11.18.1 Synergy Pharmaceuticals, Inc (US) Company Profile and Recent Development

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction

    • 11.19 Astellas Pharma Inc (Japan)

      • 11.19.1 Astellas Pharma Inc (Japan) Company Profile and Recent Development

      • 11.19.2 Market Performance

      • 11.19.3 Product and Service Introduction

    • 11.20 Abbott Laboratories (US)

      • 11.20.1 Abbott Laboratories (US) Company Profile and Recent Development

      • 11.20.2 Market Performance

      • 11.20.3 Product and Service Introduction

    • 11.21 Sucampo Pharmaceuticals (US)

      • 11.21.1 Sucampo Pharmaceuticals (US) Company Profile and Recent Development

      • 11.21.2 Market Performance

      • 11.21.3 Product and Service Introduction

    • 11.22 Ipsen (France)

      • 11.22.1 Ipsen (France) Company Profile and Recent Development

      • 11.22.2 Market Performance

      • 11.22.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 113 Figures and 143 Tables)

    • Figure Product Picture

    • Figure IBS Treatment Market Size and Growth Rate of IBS-D from 2014 to 2026

    • Figure IBS Treatment Market Size and Growth Rate of IBS-C from 2014 to 2026

    • Figure IBS Treatment Market Size and Growth Rate of IBS-M from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global IBS Treatment Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Global IBS Treatment Market Size and Growth Rate of Clinics from 2014 to 2026

    • Figure Global IBS Treatment Market Size and Growth Rate of Research Laboratories from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina IBS Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of IBS Treatment Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of IBS Treatment

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of IBS Treatment by Different Types from 2014 to 2026

    • Table Consumption Share of IBS Treatment by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of IBS-D

    • Figure Market Size and Growth Rate of IBS-C

    • Figure Market Size and Growth Rate of IBS-M

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of IBS Treatment by Different End-Users from 2014 to 2026

    • Table Consumption Share of IBS Treatment by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Research Laboratories

    • Table Global IBS Treatment Production by Major Regions

    • Table Global IBS Treatment Production Share by Major Regions

    • Figure Global IBS Treatment Production Share by Major Regions in 2014

    • Figure Global IBS Treatment Production Share by Major Regions in 2018

    • Figure Global IBS Treatment Production Share by Major Regions in 2026

    • Table Global IBS Treatment Consumption by Major Regions

    • Table Global IBS Treatment Consumption Share by Major Regions

    • Figure Global IBS Treatment Consumption Share by Major Regions in 2014

    • Figure Global IBS Treatment Consumption Share by Major Regions in 2018

    • Figure Global IBS Treatment Consumption Share by Major Regions in 2026

    • Table North America IBS Treatment Production, Import, Consumption and Export Analysis

    • Table Europe IBS Treatment Production, Import, Consumption and Export Analysis

    • Table Asia Pacific IBS Treatment Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa IBS Treatment Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in IBS Treatment market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in IBS Treatment market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in IBS Treatment market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in IBS Treatment market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America IBS Treatment Consumption by Types from 2014 to 2026

    • Table North America IBS Treatment Consumption Share by Types from 2014 to 2026

    • Figure North America IBS Treatment Consumption Share by Types in 2014

    • Figure North America IBS Treatment Consumption Share by Types in 2018

    • Figure North America IBS Treatment Consumption Share by Types in 2026

    • Table North America IBS Treatment Consumption by End-Users from 2014 to 2026

    • Table North America IBS Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure North America IBS Treatment Consumption Share by End-Users in 2014

    • Figure North America IBS Treatment Consumption Share by End-Users in 2018

    • Figure North America IBS Treatment Consumption Share by End-Users in 2026

    • Table North America IBS Treatment Consumption by Major Countries from 2014 to 2026

    • Table North America IBS Treatment Consumption Share by Major Countries from 2014 to 2026

    • Figure North America IBS Treatment Consumption Share by Major Countries in 2014

    • Figure North America IBS Treatment Consumption Share by Major Countries in 2018

    • Figure North America IBS Treatment Consumption Share by Major Countries in 2026

    • Figure United States IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Table Europe IBS Treatment Consumption by Types from 2014 to 2026

    • Table Europe IBS Treatment Consumption Share by Types from 2014 to 2026

    • Figure Europe IBS Treatment Consumption Share by Types in 2014

    • Figure Europe IBS Treatment Consumption Share by Types in 2018

    • Figure Europe IBS Treatment Consumption Share by Types in 2026

    • Table Europe IBS Treatment Consumption by End-Users from 2014 to 2026

    • Table Europe IBS Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Europe IBS Treatment Consumption Share by End-Users in 2014

    • Figure Europe IBS Treatment Consumption Share by End-Users in 2018

    • Figure Europe IBS Treatment Consumption Share by End-Users in 2026

    • Table Europe IBS Treatment Consumption by Major Countries from 2014 to 2026

    • Table Europe IBS Treatment Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe IBS Treatment Consumption Share by Major Countries in 2014

    • Figure Europe IBS Treatment Consumption Share by Major Countries in 2018

    • Figure Europe IBS Treatment Consumption Share by Major Countries in 2026

    • Figure Germany IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure UK IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure France IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific IBS Treatment Consumption by Types from 2014 to 2026

    • Table Asia Pacific IBS Treatment Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific IBS Treatment Consumption Share by Types in 2014

    • Figure Asia Pacific IBS Treatment Consumption Share by Types in 2018

    • Figure Asia Pacific IBS Treatment Consumption Share by Types in 2026

    • Table Asia Pacific IBS Treatment Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific IBS Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific IBS Treatment Consumption Share by End-Users in 2014

    • Figure Asia Pacific IBS Treatment Consumption Share by End-Users in 2018

    • Figure Asia Pacific IBS Treatment Consumption Share by End-Users in 2026

    • Table Asia Pacific IBS Treatment Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific IBS Treatment Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific IBS Treatment Consumption Share by Major Countries in 2014

    • Figure Asia Pacific IBS Treatment Consumption Share by Major Countries in 2018

    • Figure Asia Pacific IBS Treatment Consumption Share by Major Countries in 2026

    • Figure China IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandIBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure India IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa IBS Treatment Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa IBS Treatment Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa IBS Treatment Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa IBS Treatment Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa IBS Treatment Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa IBS Treatment Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa IBS Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa IBS Treatment Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa IBS Treatment Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa IBS Treatment Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa IBS Treatment Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa IBS Treatment Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa IBS Treatment Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa IBS Treatment Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa IBS Treatment Consumption Share by Major Countries in 2026

    • Figure GCC Countries IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina IBS Treatment Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Ironwood Pharmaceuticals, Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ironwood Pharmaceuticals, Inc (US)

    • Figure Sales and Growth Rate Analysis of Ironwood Pharmaceuticals, Inc (US)

    • Figure Revenue and Market Share Analysis of Ironwood Pharmaceuticals, Inc (US)

    • Table Product and Service Introduction of Ironwood Pharmaceuticals, Inc (US)

    • Table Company Profile and Development Status of Probi (Sweden)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Probi (Sweden)

    • Figure Sales and Growth Rate Analysis of Probi (Sweden)

    • Figure Revenue and Market Share Analysis of Probi (Sweden)

    • Table Product and Service Introduction of Probi (Sweden)

    • Table Company Profile and Development Status of Innovate Biopharmaceuticals (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Innovate Biopharmaceuticals (US)

    • Figure Sales and Growth Rate Analysis of Innovate Biopharmaceuticals (US)

    • Figure Revenue and Market Share Analysis of Innovate Biopharmaceuticals (US)

    • Table Product and Service Introduction of Innovate Biopharmaceuticals (US)

    • Table Company Profile and Development Status of Alfasigma USA, Inc (Italy)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alfasigma USA, Inc (Italy)

    • Figure Sales and Growth Rate Analysis of Alfasigma USA, Inc (Italy)

    • Figure Revenue and Market Share Analysis of Alfasigma USA, Inc (Italy)

    • Table Product and Service Introduction of Alfasigma USA, Inc (Italy)

    • Table Company Profile and Development Status of Pfizer Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc (US)

    • Figure Sales and Growth Rate Analysis of Pfizer Inc (US)

    • Figure Revenue and Market Share Analysis of Pfizer Inc (US)

    • Table Product and Service Introduction of Pfizer Inc (US)

    • Table Company Profile and Development Status of Valeant Pharmaceuticals (Canada)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals (Canada)

    • Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals (Canada)

    • Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals (Canada)

    • Table Product and Service Introduction of Valeant Pharmaceuticals (Canada)

    • Table Company Profile and Development Status of Synthetic Biologics, Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synthetic Biologics, Inc (US)

    • Figure Sales and Growth Rate Analysis of Synthetic Biologics, Inc (US)

    • Figure Revenue and Market Share Analysis of Synthetic Biologics, Inc (US)

    • Table Product and Service Introduction of Synthetic Biologics, Inc (US)

    • Table Company Profile and Development Status of RedHill Biopharma Ltd (Israel)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of RedHill Biopharma Ltd (Israel)

    • Figure Sales and Growth Rate Analysis of RedHill Biopharma Ltd (Israel)

    • Figure Revenue and Market Share Analysis of RedHill Biopharma Ltd (Israel)

    • Table Product and Service Introduction of RedHill Biopharma Ltd (Israel)

    • Table Company Profile and Development Status of Nestle (Switzerland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nestle (Switzerland)

    • Figure Sales and Growth Rate Analysis of Nestle (Switzerland)

    • Figure Revenue and Market Share Analysis of Nestle (Switzerland)

    • Table Product and Service Introduction of Nestle (Switzerland)

    • Table Company Profile and Development Status of Sebela Pharmaceuticals (Ireland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sebela Pharmaceuticals (Ireland)

    • Figure Sales and Growth Rate Analysis of Sebela Pharmaceuticals (Ireland)

    • Figure Revenue and Market Share Analysis of Sebela Pharmaceuticals (Ireland)

    • Table Product and Service Introduction of Sebela Pharmaceuticals (Ireland)

    • Table Company Profile and Development Status of Novartis AG (Switzerland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG (Switzerland)

    • Figure Sales and Growth Rate Analysis of Novartis AG (Switzerland)

    • Figure Revenue and Market Share Analysis of Novartis AG (Switzerland)

    • Table Product and Service Introduction of Novartis AG (Switzerland)

    • Table Company Profile and Development Status of Ardelyx, Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ardelyx, Inc (US)

    • Figure Sales and Growth Rate Analysis of Ardelyx, Inc (US)

    • Figure Revenue and Market Share Analysis of Ardelyx, Inc (US)

    • Table Product and Service Introduction of Ardelyx, Inc (US)

    • Table Company Profile and Development Status of AstraZeneca (UK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca (UK)

    • Figure Sales and Growth Rate Analysis of AstraZeneca (UK)

    • Figure Revenue and Market Share Analysis of AstraZeneca (UK)

    • Table Product and Service Introduction of AstraZeneca (UK)

    • Table Company Profile and Development Status of Protagonist Therapeutics Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Protagonist Therapeutics Inc (US)

    • Figure Sales and Growth Rate Analysis of Protagonist Therapeutics Inc (US)

    • Figure Revenue and Market Share Analysis of Protagonist Therapeutics Inc (US)

    • Table Product and Service Introduction of Protagonist Therapeutics Inc (US)

    • Table Company Profile and Development Status of Takeda Pharmaceutical Company Ltd (Japan)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Company Ltd (Japan)

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Company Ltd (Japan)

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Company Ltd (Japan)

    • Table Product and Service Introduction of Takeda Pharmaceutical Company Ltd (Japan)

    • Table Company Profile and Development Status of Allergan Plc (Ireland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan Plc (Ireland)

    • Figure Sales and Growth Rate Analysis of Allergan Plc (Ireland)

    • Figure Revenue and Market Share Analysis of Allergan Plc (Ireland)

    • Table Product and Service Introduction of Allergan Plc (Ireland)

    • Table Company Profile and Development Status of Lexicon Pharmaceuticals, Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lexicon Pharmaceuticals, Inc (US)

    • Figure Sales and Growth Rate Analysis of Lexicon Pharmaceuticals, Inc (US)

    • Figure Revenue and Market Share Analysis of Lexicon Pharmaceuticals, Inc (US)

    • Table Product and Service Introduction of Lexicon Pharmaceuticals, Inc (US)

    • Table Company Profile and Development Status of Synergy Pharmaceuticals, Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synergy Pharmaceuticals, Inc (US)

    • Figure Sales and Growth Rate Analysis of Synergy Pharmaceuticals, Inc (US)

    • Figure Revenue and Market Share Analysis of Synergy Pharmaceuticals, Inc (US)

    • Table Product and Service Introduction of Synergy Pharmaceuticals, Inc (US)

    • Table Company Profile and Development Status of Astellas Pharma Inc (Japan)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma Inc (Japan)

    • Figure Sales and Growth Rate Analysis of Astellas Pharma Inc (Japan)

    • Figure Revenue and Market Share Analysis of Astellas Pharma Inc (Japan)

    • Table Product and Service Introduction of Astellas Pharma Inc (Japan)

    • Table Company Profile and Development Status of Abbott Laboratories (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories (US)

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories (US)

    • Figure Revenue and Market Share Analysis of Abbott Laboratories (US)

    • Table Product and Service Introduction of Abbott Laboratories (US)

    • Table Company Profile and Development Status of Sucampo Pharmaceuticals (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sucampo Pharmaceuticals (US)

    • Figure Sales and Growth Rate Analysis of Sucampo Pharmaceuticals (US)

    • Figure Revenue and Market Share Analysis of Sucampo Pharmaceuticals (US)

    • Table Product and Service Introduction of Sucampo Pharmaceuticals (US)

    • Table Company Profile and Development Status of Ipsen (France)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ipsen (France)

    • Figure Sales and Growth Rate Analysis of Ipsen (France)

    • Figure Revenue and Market Share Analysis of Ipsen (France)

    • Table Product and Service Introduction of Ipsen (France)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US